沙特阿拉伯王国政府所属的官方政府网站。

周日 16 八月 2026

沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

在数字政府管理局注册,编号:

20250831619

建议

A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell transplantation

A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell transplantation

2020-07-04

عنوان الدراسة

A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell transplantation

دواء الدراسة

Ruxolitinib (INC424) (Jakavi)

رقم بروتوكول الدراسة

CINC424C2301

حالة الدراسة

Ongoing

موقع الدراسة

King Faisal Specialist Hospital and Research Center (Riyadh)

مرحلة الدراسة

3